The Environmental Protection Agency is delaying the release of a draft assessment on formaldehyde that finds the chemical causes nasal and oral cancer and leukemia, according to Politico.
Using cancer to fight cancer might seem counterintuitive, but there’s method to the apparent madness and, according to proof-of-principle animal experiments reported in Science Translational Medicine today (July 11), it works. Tumor cells engineered to secrete anticancer agents yet resist self-destruction can be used to kill tumors in mice and then, in a fate befitting this act …
Acombination drug therapy that inhibits the TORC1 pathway involved in immune responses boosted the health of people 65 years and older, according to research published in Science Translational Medicine yesterday.
Exosomes in the blood that originated from brain cells carry biomarkers that indicate the severity of traumatic brain injuries, researchers reported in Brain Injuryin June. The authors say certain proteins in these vesicles could help predict the progression and long-term effects of the brain damage.
he US Food and Drug Administration today (June 25) approved for the first time a marijuana-derived drug, Epidiolex, for the treatment of two rare forms of epilepsy. The drug contains cannabidiol, or CBD, and does not make users high while reducing the rate of seizures in patients with Dravet or Lennox-Gastaut syndromes, clinical trials show.
Older individuals with high blood pressure are more likely to have brain lesions than those without high blood pressure and may also have protein tangles, a sign of Alzheimer’s disease, according to a study published in Neurology on July 11.
Mutaz Musa’s recent opinion piece in The Scientist predicts that AI will replace radiologists as interpreters of medical images. As a radiologist for the past 38 years, I disagree. It is impossible for me to argue that AI software will never (as in, within millennia) be able to perform at a human level. Instead, I will argue a much more tightly …
The US Food and Drug Administration’s “breakthrough therapy” designation has helped expedite the development and approval of more than 45 therapeutics in the last 5 years. But a study published in JAMA today (July 17) suggests that these interventions gain Food and Drug Administration (FDA) approval on the basis of weaker clinical evidence than those that don’t …
Patterns of brain activity associated with anxiety in monkeys are passed from parent to child, researchers report today (July 30) in the Journal of Neuroscience. The results could give clues to the heritability of severe anxiety in humans and how to treat it.
Ultrasound and microbubbles can safely open the blood-brain barrier in patients with Alzheimer’s disease, researchers reported yesterday (July 25) in Nature Communications and at the Alzheimer’s Association International Conference in Chicago. The noninvasive technique could aid in getting therapies for the neurodegenerative disease straight to the brain.